These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37885030)

  • 41. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
    Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
    Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
    Zeng X; Ma X; Guo H; Wei L; Zhang Y; Sun C; Han N; Sun S; Zhang N
    Bioengineered; 2021 Dec; 12(2):10126-10135. PubMed ID: 34978519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1.
    Li X; Li J; Xu L; Wei W; Cheng A; Zhang L; Zhang M; Wu G; Cai C
    J Exp Clin Cancer Res; 2022 Apr; 41(1):149. PubMed ID: 35449080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer.
    Lv ZD; Xin HN; Yang ZC; Wang WJ; Dong JJ; Jin LY; Li FN
    J Cell Physiol; 2019 Jul; 234(7):10819-10826. PubMed ID: 30624764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
    Bilir B; Kucuk O; Moreno CS
    J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma.
    Yin DF; Zhou XJ; Li N; Liu HJ; Yuan H
    Bioengineered; 2021 Dec; 12(1):1189-1201. PubMed ID: 34969359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ETHE1 Accelerates Triple-Negative Breast Cancer Metastasis by Activating GCN2/eIF2α/ATF4 Signaling.
    Yang SY; Liao L; Hu SY; Deng L; Andriani L; Zhang TM; Zhang YL; Ma XY; Zhang FL; Liu YY; Li DQ
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
    Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
    Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circ_0041732 regulates tumor properties of triple-negative breast cancer cells by the miR-149-5p/FGF5 pathway.
    Li H; Yin H; Yan Y
    Int J Biol Markers; 2022 Jun; 37(2):178-190. PubMed ID: 35341378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
    Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
    Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
    Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
    Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
    Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
    Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
    Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
    Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer.
    Hou L; Chen M; Yang H; Xing T; Li J; Li G; Zhang L; Deng S; Hu J; Zhao X; Jiang J
    Med Sci Monit; 2016 Oct; 22():3666-3672. PubMed ID: 27731867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer.
    Metcalf S; Dougherty S; Kruer T; Hasan N; Biyik-Sit R; Reynolds L; Clem BF
    Clin Exp Metastasis; 2020 Feb; 37(1):187-197. PubMed ID: 31630284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.